Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104130261A reveals a green synthetic route for Idelalisib. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112174970B reveals a scalable method for Pemetrexed Disodium using alkali-modified molecular sieves, ensuring high yield and reduced environmental impact.
Patent CN113024521B reveals a streamlined 5-step synthesis for Entrectinib, offering high purity and mild conditions for reliable API intermediate supply chains.
Patent CN108409626A details a novel route for Rucaparib intermediates offering enhanced purity and cost efficiency for global pharmaceutical supply chains.
Patent CN113214255A details a scalable four-step synthesis of 2,6-diazaspiro[3.5]nonane intermediates, offering cost-effective routes for pharmaceutical manufacturing.
Explore CN115043784B patent technology for high-purity biphenyl-1,2,3-triazole synthesis. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable click chemistry.
Patent CN104844514B discloses novel diarylpyrazole derivatives with potent androgen receptor antagonism. Explore scalable synthesis and supply chain advantages for pharmaceutical intermediates.
Patent CN109180592B details a green synthesis of 7-chloro-2-(3-chlorophenyl)quinazoline using NNN-Ru catalysts. Discover cost-effective, scalable manufacturing solutions.
Novel gold-catalyzed synthesis of indanone imine derivatives with potent anti-tumor activity. Efficient route for API intermediates ensuring cost reduction and supply stability.
Patent CN102627614B details a robust synthesis of bisquinazoline diselenides. This report analyzes cost-effective manufacturing and supply chain reliability for oncology intermediates.
Patent CN110885298B details a green synthesis route for Sorafenib intermediates, offering high purity and reduced waste for reliable pharmaceutical supply chains.
Patent CN102050775A details a novel method for synthesizing and isolating a critical succinimide-based impurity of Anastrozole, ensuring robust quality control and supply chain reliability for API manufacturers.
Discover a high-yield Melphalan synthesis route using L-phenylalanine. Optimized for cost reduction in pharmaceutical manufacturing with superior impurity control.
Novel low-palladium Heck cyclization route for 6-bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one. Reduces cost and waste.
Novel chiral catalytic hydrogenation route for Duvelisib reduces steps and improves safety for reliable API intermediate supply.
Patent CN111377982B details a novel solid acid catalyzed glycosylation for decitabine intermediates, offering high beta-selectivity and simplified purification for pharmaceutical manufacturing.
Patent CN111100123A details a high-yield, six-step ellipticine synthesis avoiding column chromatography. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis method for Syk inhibitor intermediate via selective nitration and hydrazine reduction, offering high yield and scalability for pharma supply chains.
Patent CN103864877A reveals a high-yield Suzuki coupling route for Abiraterone Acetate, offering significant cost reduction and greener manufacturing for pharmaceutical intermediates.
Advanced synthesis of 5-oxo-tetrahydropyran-3-carboxylic ester via Pd-catalyzed carbonylation. Offers cost reduction in API manufacturing and scalable production.